Angiogenic growth factors are essential for cancer metastasis, and the growth of metastatic foci also depends on these angiogenic growth factors as well as autocrine or paracrine growth factors. We therefore investigated whether vascular endothelial growth factor (VEGF) and thymidine phosphorylase (dThdPase) are localized more often in primary tumors with hepatic metastasis than in those without such metastasis and whether transforming growth factor (TGF-α) and epidermal growth factor receptor (EGF-R) are coexisted more often in hepatic metastases than in primary tumors of gastric cancer.
Resected specimens from 82 patients with gastric cancer were examined immunohisto-chemically. The primary antibodies used were anti-VEGF, anti-dThdPase, anti-TGF-α and anti-EGF-R.
VEGF expression was found to be higher in primary cancers with than in those without hepatic metastasis (p<0.001), while VEGF was frequently observed in both hepatic metas-tases and in the primary tumors. Localization of dThdPase was also higher in advanced than in early gastric cancers (p=0.021). High co-presence of TGF-α and EGF-R was detected more frequently in cancers with deep gastric wall invasion than in those without such invasion (p=0.050), and also more often in cancers with venous invasion (p=0.007) and those in the advanced stage (p=0.020). Co-presence of TGF-α and EGF-R was found to be higher, though not significantly, in hepatic metastases (58.8%) than in primary tumors (29.4%).
These findings suggest that localization of VEGF may play an important role in hepatic metastasis, and that the expression of VEGF, dThdPase and the TGF-α/EGF-R pathway may be responsible for the growth of hepatic metastasis. (J Nippon Med Sch 1998; 65: 358-366)